Abram M. Goldfinger has been selected as one of the 40 top business leaders in the area under age 40 by the Philadelphia Business Journal. Mr. Goldfinger is Director of Thomas Jefferson University's Office of Technology Transfer. He was honored by the newspaper for his efforts in commercializing the University's biomedical technologies.

Jefferson's Technology Transfer Program identifies basic and clinical research projects and guides their development into marketable products. Mr. Goldfinger helps to launch start-up companies based on emerging biomedical technology. Projects have drawn on a variety of research, including therapeutics, diagnostics and medical devices.

During fiscal year 1999, Jefferson filed applications for 37 new patents. The average number of new applications filed and patents granted in the last five years was more than double the average from the prior five years. Total license income has grown dramatically as well, more than doubling this fiscal year from the previous one.

Jefferson ranked in the top 15 universities nationally in new research funding from technology licensing in each of the past three surveys of technology transfer activity at universities in the United States.

In the past five years, 16 companies based on Thomas Jefferson University technologies have been created. In two of the past three published annual surveys of technology transfer at universities, Jefferson ranked in the top 10 nationally in the number of start-up companies created based on university technology.

"Jefferson's record of accomplishment is a credit to our researchers," says Mr. Goldfinger. "It's a credit to both their scientific achievements and their entrepreneurial spirit."

News Briefs | Photo Album | Calendar | Announcements | Notables